Discovery and development of targeted therapeutics using human intelligence of experienced drug hunters
Discovery and development of targeted therapeutics using human intelligence of experienced drug hunters
Signed in as:
filler@godaddy.com
Discovery and development of targeted therapeutics using human intelligence of experienced drug hunters
Discovery and development of targeted therapeutics using human intelligence of experienced drug hunters
Akttyva Therapeutics, Inc. is a drug-discovery company founded by a team of pharmaceutical industry veterans, scientists and entrepreneurs to accelerate drug development. Our drug-discovery AI-assisted platform, AIDE-360, has won numerous awards, most notably, National Science Foundation, IBM and MassChallenge.
Akttyva Therapeutics co-founders have developed an evidence-based drug-discovery platform based on decades of expertise in biology, drug discovery and computational science. The platform is based on integrated AI tools and physics-based approaches, unique libraries of drug-like molecules and an experimental confirmation of predictions to bring new therapies to patients at an accelerated pace.
Akttyva is developing therapies for conditions with vascular leakage pathologies focusing on activation of the targets involved in endothelial vasculature function.
Please reach out to us: +1-617-821-7095
155 Arlington Street, Watertown, Massachusetts 02472, United States